AU2011212490B2 — Assembly for a drug delivery device and drug delivery device
Assigned to Sanofi Aventis Deutschland GmbH · Expires 2014-08-21 · 12y expired
What this patent protects
An assembly for a drug delivery device (1) comprises a housing (11), at least one stop feature (36) and at least one blocking member (34). For setting a dose of a drug (5), the stop feature (36) is configured to be rotated in a dose setting direction with respect to the blocking …
USPTO Abstract
An assembly for a drug delivery device (1) comprises a housing (11), at least one stop feature (36) and at least one blocking member (34). For setting a dose of a drug (5), the stop feature (36) is configured to be rotated in a dose setting direction with respect to the blocking member (34) and with respect to the housing (11). For delivering the set dose of the drug (5), the blocking member (34) is configured to be axially displaced with respect to the stop feature (36) away from an axial starting position and towards an axial interaction position. When the blocking member (34) is in the axial starting position, the blocking member (34) is axially offset from the stop feature (36) and, when the blocking member (34) is in the axial interaction position, the blocking member (34) is configured to mechanically cooperate with the stop feature (36) such that rotation of the stop feature (36) in the dose setting direction with respect to the housing (11) is prevented.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.